SIRION Biotech Plans Opening of a New Office in the Boston Area

BOSTON & MUNICH -- SIRION Biotech, a leading viral vector platform company known for creating high quality viral vector solutions for industry and academic partners, today announced its commitment to open a new office in the vicinity of Boston. The announcement was made during the 2015 BIO International Convention taking place this week in Philadelphia, [...]

George Washington University Professor’s Technology Offers Advanced Detection in Drug and Other Healthcare Screenings

WASHINGTON -- A George Washington University professor has designed new technology that can identify traces of chemicals at 10-19 moles, a previously undetectable amount. This minute quantity can be conceptualized as 10 times below a billionth of a billionth of a teaspoon of water. Akos Vertes, professor of chemistry in the GW Columbian College of [...]

SINGLE-CELL EPIGENETICS COMES TO THE FLUIDIGM C1™ SYSTEM

SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced the availability of Single-Cell ATAC-seq, an epigenetics application for the C1TM system, that allows researchers to explore the regulatory systems that drive cellular function. This application is freely available to researchers on Script Hub™, a new web portal within Fluidigm’s C1 Open App™ program. As [...]

Exosomes for Regenerative Medicine Research

AMSBIO has launched a new range of human exosomes to the regenerative medicine tools and technologies market. Derived from placental and adipose derived stem cells, to ensure consistent high quality, these new products are ideally suited for research involving wound healing, stem cell differentiation and tissue regeneration. Exosomes are small vesicles (30–150 nm) containing sophisticated [...]

Deben reports on how the University of Portsmouth use in situ µXCT compressive testing to help answer how materials respond to complex loading conditions

Woolpit, United Kingdom: Deben, a leading provider of in-situ testing stages together with innovative accessories and components for electron microscopy, report on the µXCT in situ testing being carried out in the School of Engineering at the University of Portsmouth. Professor Jie Tong leads the Mechanical Behaviour of Materials group at the University of Portsmouth, [...]

New AMRI Drug Discovery Center to Enable Translational Research Platforms

BUFFALO, N.Y. -- As further evidence of Governor Andrew M. Cuomo's successful establishment of a dynamic and growing bio-pharma sector in Buffalo, New York, Albany Molecular Research Inc. (NASDAQ: AMRI) and PerkinElmer, Inc. today announced the formation of a strategic collaboration in connection with the opening of AMRI's drug discovery center as part of the [...]

SYGNIS AG signs non-exclusive distribution agreement with Scandinavian Biotop Oy for Finland

Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio with Biotop Oy for Finland. Under the terms of the agreement, SYGNIS has granted Biotop the non-exclusive rights to promote, market and [...]

David Newble joins TTP Labtech as new managing director

Melbourn, UK -- TTP Labtech, a world leader in the design and development of automated instrumentation and consumables for life science applications, is pleased to announce the appointment of David Newble as its new managing director. Dr. Jas Sangera, founder, managing director and key driver for the company for the last 14 years, will continue [...]

HighRes Biosolutions Announces a Partnership with Axel Johnson

WOBURN, Mass. -- HighRes Biosolutions (“HighRes”), a leading manufacturer of laboratory automation systems and devices, announced today the sale of a majority interest in the company to Axel Johnson, Inc., a private company owned by the Johnson family of Stockholm, Sweden. The partnership between the two companies is intended to add financial strength and resources [...]

Twist Bioscience Names Solange Glaize As Chief Financial Officer

SAN FRANCISCO -- Twist Bioscience, a company focused on synthetic DNA, today announced the appointment of Solange Glaize, former corporate controller and chief accounting officer for Agilent Technologies, to the newly created position of chief financial officer. "We are thrilled to welcome Solange to our executive team, as she will be instrumental in helping us [...]

Access IBO on Knowledge Center